POCUYTO: Positive and Quantitative Diagnosis of Pleural Effusions by Thoracic Ultrasonography in Patients With Acute Respiratory Failure in the Emergency Department

Sponsor
University Hospital, Limoges (Other)
Overall Status
Terminated
CT.gov ID
NCT03846934
Collaborator
(none)
167
1
20.5
8.1

Study Details

Study Description

Brief Summary

Acute respiratory failure (ARF) is a frequent reason for consulting in the Emergency Department (ED) and one of the major clinical problems prompting admission in intensive care unit. In the ED, evaluation of an ARF is mainly based on clinical examination and frontal chest x-ray performed to the patient bedside. This practice has a limited diagnostic capacity due to a lack of specificity of clinical and radiological semiology, especially in the polypathological patient. Thoracic ultrasonography provides morphological information regrouped as a syndrome (interstitial syndrome, alveolar condensation, pneumothorax) and allows the identification of pleural effusions (PE). The PE diagnosis is easy, quick, and relies on two-dimensional ultrasound imaging. Compared to CT scan, which remains the reference examination although ill-suited in the context of emergency, thoracic ultrasonography has a sensitivity and specificity greater than 90% for pleural liquid (PL) diagnosis. In addition, thoracic ultrasonography is used to assess the volume of PL, determine its nature and guide the pleural puncture with higher performance than chest x-ray. The semi-quantitative evaluation of PEs has been validated in patients with mechanical ventilation hospitalized in intensive care unit. On the other hand, few data on the prevalence and quantification of PL for hospitalized patients in ED for an ARF are currently available.

Thus, the objective of this study is to evaluate the prevalence and severity of the PL identified by thoracic ultrasonography in patients admitted to the ED for an ARF by emergency physicians with ultrasound skills recommended by the French Society of Emergency Medicine.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasonography thoracic

Detailed Description

Acute respiratory failure (ARF) is a frequent reason for consulting in the Emergency Department (ED) and one of the major clinical problems prompting admission in intensive care unit. In the ED, evaluation of an ARF is mainly based on clinical examination and frontal chest x-ray performed to the patient bedside. This practice has a limited diagnostic capacity due to a lack of specificity of clinical and radiological semiology, especially in the polypathological patient. Thoracic ultrasonography provides morphological information regrouped as a syndrome (interstitial syndrome, alveolar condensation, pneumothorax) and allows the identification of pleural effusions (PE). The PE diagnosis is easy, quick, and relies on two-dimensional ultrasound imaging. Compared to CT scan, which remains the reference examination although ill-suited in the context of emergency, thoracic ultrasonography has a sensitivity and specificity greater than 90% for PL diagnosis. In addition, thoracic ultrasonography is used to assess the volume of PL, determine its nature and guide the pleural puncture with higher performance than chest x-ray. The semi-quantitative evaluation of PEs has been validated in patients with mechanical ventilation hospitalized in intensive care unit. On the other hand, few data on the prevalence and quantification of PL for hospitalized patients in ED for an ARF are currently available.

Thus, the objective of this study is to evaluate the prevalence and severity of the PL identified by thoracic ultrasonography in patients admitted to the ED for an ARF by emergency physicians with ultrasound skills recommended by the French Society of Emergency Medicine.

Study Design

Study Type:
Observational
Actual Enrollment :
167 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Positive and Quantitative Diagnosis of Pleural Effusions by Thoracic Ultrasonography in Patients With Acute Respiratory Failure in the Emergency Department
Actual Study Start Date :
Dec 3, 2019
Actual Primary Completion Date :
Aug 18, 2021
Actual Study Completion Date :
Aug 18, 2021

Arms and Interventions

Arm Intervention/Treatment
Ultrasonography thoracic

Ultrasonography thoracic

Device: Ultrasonography thoracic
Thoracic ultrasonography will be performed as soon as possible after admission to the ED, without delaying the start of treatment and in addition to routine thoracic radiography.

Outcome Measures

Primary Outcome Measures

  1. Clinically relevant Pleural Effusions (PE) [Day 1]

    Number and proportion of ARF patients for whom the thoracic ultrasonography realized in ED shows a clinically relevant PE (> 2cm)

Secondary Outcome Measures

  1. Inter-pleural distance to the inspiration [Day 1]

    Measuring of the inter-pleural distance to the inspiration (patient in spontaneous ventilation) in cross-section

  2. Additional diagnostic elements [Day 1]

    Number and proportion of patients for whom the thoracic ultrasound provides additional diagnostic evidence in comparison to clinical examination and the standard thoracic radiography in frontal bed, ie: Presence of an PE Abundant PE> 800 mL Or any other pleuro-parenchymal abnormalities identified by ultrasound (pneumothorax, condensation of lung parenchyma ...) and not on standard radiography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient admitted to the ED

  • AND Age >= 18 years

  • AND affiliated or beneficiary to a social security scheme

  • AND with clinical signs of ARF:

  • Cyanosis, mottling, encephalopathy

  • Respiratory exhaustion (thoraco abdominal balancing, accessory muscle play)

  • Pulse oxygen saturation (SpO2) <92% in the air

  • AND/OR showing biological signs of ARF:

  • Arterial oxygen pressure (PaO2) <60 mmHg

  • Or PaO2 / fraction of inspired oxygen (FiO2) ratio <400.

Exclusion Criteria:
  • Patient moribund or for whom a limitation of the care is envisaged

  • Pregnant woman

  • Absence of exploitable ultrasound image for any reason.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Limoges Limoges France 87042

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT03846934
Other Study ID Numbers:
  • 87RI18_032 (POCUYTO)
First Posted:
Feb 20, 2019
Last Update Posted:
Oct 7, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Limoges
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 7, 2021